-
Pillcam COLON 2 for Investigation of the COLON Through Direct Visualization: A Systematic Review
Sep 9, 2025, 16:22 PM -
Global Trade Shocks and Exchange Rate Effects on Pharmaceutical Reference Pricing: Implications of EU Stimulus for US MFN Policy
Sep 9, 2025, 16:22 PM -
Gender Inequalities in Aortic and Mitral Valve Interventions in Sweden
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Modern Biologics Compared to Conventional Therapies in AQP-4 Positive Neuromyelitis Optica Spectrum Disorder: A Fully AI-Automated Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Incentivizing Access to New Drugs in Psychiatry: Exploration of a Subscription Payment Approach to Overcome Barriers to European Launch
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Aztreonam Avibactam (ATMAVI) ± Metronidazole (MTZ) for the Treatment of Complicated Intra-Abdominal Infections (cIAIs) and Ventilator-Associated Hospital-Acquired Pneumonia (HAP/VAP) Caused by Suspected MBL-Producing...
Sep 9, 2025, 16:22 PM -
Importance of Adjudication Committees in Retrospective Chart Review Studies for Outcomes Event Data Collection
Sep 9, 2025, 16:22 PM -
The Value Flower in Bloom: Emerging Recognition of Uncaptured Benefits in NICE HTA Decisions
Sep 9, 2025, 16:22 PM -
Economic Impact of Emicizumab vs. On-Demand Therapy With Bypassing Agents in Patients With Hemophilia A With Inhibitors in Mexico
Sep 9, 2025, 16:22 PM -
Comparison of the Early Access and Postmarket Evaluation Systems in South Korea and Germany’s DIGA
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Prostate Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
The Unique Value of Detecting Preeclampsia: Comparing Health Economic Analyses of Novel Diagnostics With the ISPOR Value Flower
Sep 9, 2025, 16:22 PM -
Care Partner Burden and Experiences With Schizophrenia: A National Canadian Survey
Sep 9, 2025, 16:22 PM -
Correlation Between Ultra-Orphan Drug Costs Cost-Effectiveness Metrics and Disease Prevalence
Sep 9, 2025, 16:22 PM -
Mapping of Treatment Patterns and Transfusion Status in Danish and Swedish Myelofibrosis (MF) Patients
Sep 9, 2025, 16:22 PM -
Validating a Medication Adherence Index in Large Urban Population
Sep 9, 2025, 16:22 PM -
HTA League of Nations: Which Bodies Were Most Likely to Approve Submissions and for What Disease Areas?
Sep 9, 2025, 16:22 PM -
Instrumental Variable Treatment Effects Estimation: A Simulation Comparison of Instrumental Variables and OLS Approaches
Sep 9, 2025, 16:22 PM -
Evaluating AI Chatbot Empathy and Probing Skills in Automated Patient In-Trial Interviews: A Proof of Principle Experiment
Sep 9, 2025, 16:22 PM -
Health Technologies Using Artificial Intelligence: What Is Being Assessed in the UK by NICE?
Sep 9, 2025, 16:22 PM
